Monica Dunne
The Effect of Homœopathically Prepared Growth Factors, Signal Cell Enhancers®, in Children with HIV/AIDS
Abstract
HIV/AIDS is one of the greatest and still unresolved challenges facing the world today. The UNAIDS (2004) Reports, 38 million people are infected globally with HIV/AIDS. One of the most devastating impacts of HIV/AIDS is the effect on children.
The aim of the study was to determine the effect of a combination of four homœopathically prepared growth factors (HoGF), compounded and named Cell Signal Enhancers®, on CD4% and CD4+ cell count, growth parameters such as weight, height and head circumference and clinical outcomes in children with HIV/AIDS. Cell Signal Enhancers® consisted of four growth factors, namely IGF-1, PDGF, TGF and GM-CSF prepared homœopathically ranging from 30CH to 1M.
This study was conducted in South Africa, Johannesburg. A sample of thirty-one (n=31) HIV positive children between one to thirteen years of age was recruited. Twenty-five (n=25) participants completed the trial. The duration of the study was fourteen weeks. Each participant acted as his/her own control in a two week pre-treatment period. Analysis of CD4% and CD4+ cell count, measurements of growth parameters that included weight, height and head circumference and evaluation of the clinical outcomes were conducted pre-treatment, during treatment and post treatment. Treatment was given three times a day, for a twelve week period. Statistical models such as a paired t-test, one-sample t-test and linear regression were used to analyse the data.
The resultant analyses of the data demonstrated that HoGF treatment improved immune function of the participants, as there were increases in CD4% and CD4+ cell counts and an overall decrease in frequency of HIV symptoms. There were significant increases in weight, height and head circumference. HoGF treatment was effective in each stage of HIV/AIDS; namely the asymptomatic, symptomatic and AIDS group.
HoGF has proven to be effective in treating HIV infected children living with limited resources. It showed a 52% positive result as statistically significant versus a 5% prediction by random chance. Statistical significance was detected in the following; height, head circumference, energy, strength, vomiting, lymphadenopathy, skin lesions, respiratory tract infection, sinus tenderness and throat infection. There were no reported adverse side effects on HoGF treatment.
Biography
Monica qualified with a Master’s Degree in Homœopathy from the University of Johannesburg, South Africa. Monica immigrated to Australia at the end of 2006 and is living in Perth.
In South Africa, Monica was involved in the supervision of an out-reach Homœopathic clinic, lecturing and HIV/AIDS research supervision under the University of Johannesburg. Monica had a part time private practice.
In Australia, Monica is senior lecturer and homœopathic clinic supervisor at the Australian Institute of Holistic Medicine in Jandakot, WA.
Back to previous page |